Erythropoietin resistance from failed renal allograft: Case report

Journal of Nephrology & Therapeutics

ISSN: 2161-0959

Open Access

Erythropoietin resistance from failed renal allograft: Case report

12th Global Nephrologists Annual Meeting

June 26-28, 2017 London, UK

Can Huzmeli, Mustafa Saglam and Baris Doner

Necip Faz├?┬?├?┬▒l City Hospital, Turkey

Scientific Tracks Abstracts: J Nephrol Ther

Abstract :

The reason of anaemia during chronic renal insufficiency is deficiency of erythropoietin (ESA). Risk factors for ESA resistance are absolute or functional iron deficiency, gastrointestinal blood loss, haemolysis, inflammation, infection, malignancy, folic acid and vitamin B12 deficiency, inadequate haemodialysis, hyperparathyroidisim, Angiotensin converting enzyme inhibitor, Angiotensin II receptor blocker, Anti-erythropoietin antibody and genetic polymorphism. We describe a case of 52 year old man who had a history of renal allograft failure. Three moons later he presented to the hospital with symptoms of severe anemia, hematuria, fever, exhaustion and fatigue. Due to deep anaemia, 5 times in 2 months (2U each time) erythrocyte replacement (ES) was performed. There was sensitivity in the graft site. Laboratory examinations were: Hb 5.4 gr/dl (13-17), albumin 2.2 gr/dl (3.5-5.2), ferritin >2000 ng/ml (30-100), transferrin saturate was calculated as 40%, vitamin B12 402 pg/ml (191-663), parathormon 630 pg/ml (15-65), C-reactive protein 117 mg/L (0-5), sedimentation 70 mm/hour. In the conducted peripheral spread, normochromic was compatible with normocytic anaemia. The patient was taking epoetin beta 150 U/kg vitamin D in treatment, upon no detection of reproduction in sent blood, urine and sputum cultures. Methylprednisolone (10 mg) was started with Graft intolerance syndrome (GIS) diagnosis. Patient did not have fever and did not need ES in his medical follow-ups. GIS was successfully treated with low dose steroids despite the suggestion of high dose steroids. After treatment, Hb level exceeded 12 gr/dl and he did not need erythropoetin.

Biography :

Can Huzmeli completed his MD at Cukurova University in 2002. In 2010, he completed his Residency training in Internal Medicine at Mustafa Kemal University. After completion of the Nephrology fellowship at the Cumhuriyet University in 2014, he has been working as a Nephrology Specialist at Necip Fazil City Hospital, since 2015.


Google Scholar citation report
Citations: 784

Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report

Journal of Nephrology & Therapeutics peer review process verified at publons

Indexed In

arrow_upward arrow_upward